Equity Overview
Price & Market Data
Price: $4.35
Daily Change: -$3.00 / 68.97%
Daily Range: $4.23 - $7.10
Market Cap: $61,806,924
Daily Volume: 305,937
Performance Metrics
1 Week: -44.25%
1 Month: -44.25%
3 Months: -44.25%
6 Months: -44.25%
1 Year: -44.25%
YTD: -49.02%
Company Details
Employees: 5
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin® class, a novel class of antimicrobial agents that fight infections by disrupting microbial membranes. It develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers. Lakewood-Amedex Biotherapeutics, Inc. was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June, 2025. The company was incorporated in 2006 and is headquartered in University Park, Florida.